Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome.

AKINCI B., ÇELTİK A., Yuksel F., Genc S., Yener S., SEÇİL M., ...Daha Fazla

Diabetes research and clinical practice, cilt.91, sa.1, ss.26-31, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 91 Sayı: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.diabres.2010.09.028
  • Dergi Adı: Diabetes research and clinical practice
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.26-31
  • Anahtar Kelimeler: Cardiovascular risk, Metabolic syndrome, OPG, Previous gestational diabetes
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.